Get started
Author

Roger Bentanachs

Observed names: Bentanachs Raset, Roger, Bentanachs, Roger, R. Bentanachs, R. Bentanachs Raset, Roger Bentanachs Raset
ORCID: 0000-0002-9714-163X
Observed ORCID: 0000-0002-9714-163X
OpenAlex ID: A5047514716
Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation
2020 · Ana Magdalena Velázquez, Núria Roglans, et al. · Nutrients · 45
PDF
The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo
2019 · Jana Pourová, Lenka Applová, et al. · Nutrients · 31
PDF
ChREBP‐driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High‐Fat Diet‐Fed Rat Model
2022 · Ana Magdalena Velázquez, Roger Bentanachs, et al. · Molecular Nutrition & Food Research · 30
KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid
2022 · Ana Magdalena Velázquez, Roger Bentanachs, et al. · Biomedicines · 21
PDF
FTO inhibition mitigates high-fat diet-induced metabolic disturbances and cognitive decline in SAMP8 mice
2025 · Alba Irisarri, Ana Corral, et al. · Molecular Medicine · 14
Sex Differences Affect the NRF2 Signaling Pathway in the Early Phase of Liver Steatosis: A High-Fat-Diet-Fed Rat Model Supplemented with Liquid Fructose
2024 · Benedetta Di Veroli, Roger Bentanachs, et al. · Cells · 14
PDF
Adipose Tissue Protects against Hepatic Steatosis in Male Rats Fed a High-Fat Diet plus Liquid Fructose: Sex-Related Differences
2023 · Roger Bentanachs, Laia Blanco, et al. · Nutrients · 11
PDF
Bempedoic Acid Restores Liver H2S Production in a Female Sprague-Dawley Rat Dietary Model of Non-Alcoholic Fatty Liver
2022 · Núria Roglans, Elena Fauste, et al. · International Journal of Molecular Sciences · 10
PDF
Pemafibrate abrogates SLD in a rat experimental dietary model, inducing a shift in fecal bile acids and microbiota composition
2024 · Roger Bentanachs, Lluïsa Miró, et al. · Biomedicine & Pharmacotherapy · 9
Bempedoic acid as a PPARα activator: New perspectives for hepatic steatosis treatment in a female rat experimental model
2022 · Roger Bentanachs, Ana Magdalena Velázquez, et al. · Clínica e Investigación en Arteriosclerosis (English Edition) · 7
El ácido bempedoico como activador PPARα: Nuevas perspectivas para el tratamiento de la esteatosis hepática en un modelo experimental de rata hembra
2021 · Roger Bentanachs, Ana Magdalena Velázquez, et al. · Clínica e Investigación en Arteriosclerosis · 6
PDF
Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD
2025 · Roger Bentanachs, Patricia Ramírez-Carrasco, et al. · Pharmacological Research · 5
Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition
2025 · Roger Bentanachs, Lluïsa Miró, et al. · Frontiers in Pharmacology · 2
PDF
Bempedoic acid attenuates vascular inflammation and oxidative stress in a preclinical model of abdominal aortic aneurysm
2026 · Lídia Puertas-Umbert, Judith Alonso, et al. · Clínica e Investigación en Arteriosclerosis (English Edition)
El ácido bempedoico atenúa la respuesta inflamatoria y el estrés oxidativo vascular en un modelo de aneurisma de aorta abdominal
2025 · Lídia Puertas-Umbert, Judith Alonso, et al. · Clínica e Investigación en Arteriosclerosis
Fructose consumption alone or associated with cholesterol affects serine metabolism
2025 · Elena Fauste, Raquel Lorenzo, et al. · Atherosclerosis
PDF
Exploring PPARα, β3-adrenergic and Renin/Angiotensin pathways to treat Metabolic dysfunction-Associated Steatotic Liver: A drug repurposing approach.
2025 · Bentanachs Raset, Roger · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
FRI-342 Exploring the repurposing of Telmisartan for the treatment of MASLD: characterization of its antisteatotic mechanism of action
2025 · Roger Bentanachs, Bianca Braster, et al. · Journal of Hepatology
FRI-344 Sexual dimorphism of Sprague-Dawley rats in the liver inflammatory/fibrotic response to a high in sucrose and fat, choline-deficient, L-amino acid CDAA diet
2025 · Patricia Ramírez-Carrasco, Manel Garcia-Díez, et al. · Journal of Hepatology
FRI-343 Anti-steatosis effect of telmisartan in a MASL-dietary rat model does not associates to changes in faecal bile acid metabolome
2025 · Roger Bentanachs, Patricia Ramírez-Carrasco, et al. · Journal of Hepatology
Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition
2025 · Bentanachs Raset, Roger, Miró Martí, Ma. Lluïsa, et al. · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Pemafibrate: PROMINENT failure or an urgent need for therapeutic replacement?
2023 · Juan Carlos Laguna Egea, Núria Roglans Ribas, et al. · Clínica e Investigación en Arteriosclerosis (English Edition)
Pemafibrate modulates microbiota profile in a dietary model of fatty liver in rat
2023 · Roger Bentanachs, Lluïsa Miró, et al. · Journal of Hepatology
Opposite correlations between hepatic β-oxidation activity and triglyceride levels in male and female rats after a high-fat diet supplemented with liquid fructose
2023 · Roger Bentanachs, Laia Blanco, et al. · Journal of Hepatology
Pemafibrate abrogates lipid liver accretion in a dietary model of fatty liver in rat
2023 · Roger Bentanachs, Laia Blanco, et al. · Journal of Hepatology
Works count: 34
Citation count: 202
H-index: 9
I10-index: 8
Year
Topic
Type